Results 251 to 260 of about 27,891 (313)

Periconceptional GLP-1 receptor agonist exposure and obstetric outcomes: a Danish nationwide cohort study. [PDF]

open access: yesHum Reprod Open
Hviid KVR   +7 more
europepmc   +1 more source

Real-world 6-month persistence, adherence, and effectiveness of GLP-1 medications for overweight and obesity in a Medicaid population. [PDF]

open access: yesJ Manag Care Spec Pharm
Meyer KB   +10 more
europepmc   +1 more source

New-Onset Nonarteritic Anterior Ischemic Optic Neuropathy and Initiators of Semaglutide in US Veterans With Type 2 Diabetes.

open access: yesJAMA Ophthalmol
Heberer K   +9 more
europepmc   +1 more source

Flexible dose of semaglutide reduces early discontinuation while maintaining comparable outcomes in obese patients: FLEX-SEMA 2.4 mg, an Italian real-world study. [PDF]

open access: yesDiabetes Obes Metab
Pampanelli S   +12 more
europepmc   +1 more source

Not All Weight Loss Is Equal: Towards Muscle‐Preserving Therapies in Obesity

open access: yes
Journal of Cachexia, Sarcopenia and Muscle, Volume 17, Issue 3, June 2026.
Joseph D. Abraham   +2 more
wiley   +1 more source

GLP‐1 Receptor Agonists for Obstructive Sleep Apnea: An Otolaryngologist's Prescription?

open access: yes
The Laryngoscope, Volume 136, Issue 6, Page 2406-2409, June 2026.
Alina Zgardau   +3 more
wiley   +1 more source

Home - About - Disclaimer - Privacy